Inhibition of ALK enzymatic activity in T-cell lymphoma cells induces apoptosis and suppresses proliferation and STAT3 phosphorylation independently of Jak3

This publication has 31 references indexed in Scilit:

• The JAK/STAT signaling pathway
  Journal of Cell Science, 2004
• The STATs of cancer — new molecular targets come of age
  Nature Reviews Cancer, 2004
• NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors
  Blood, 2003
• Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death
  Oncogene, 2002
• Lack of Phosphotyrosine Phosphatase SHP-1 Expression in Malignant T-Cell Lymphoma Cells Results from Methylation of the SHP-1 Promoter
  The American Journal of Pathology, 2000
• ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)
  Oncogene, 1997
• Role of the Nucleophosmin (NPM) Portion of the Non-Hodgkin’s Lymphoma-Associated NPM-Anaplastic Lymphoma Kinase Fusion Protein in Oncogenesis
  Molecular and Cellular Biology, 1997
• Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
  Proceedings of the National Academy of Sciences, 1996
• Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5).
  Proceedings of the National Academy of Sciences, 1996
• Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma
  Science, 1994